These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 8625325

  • 1. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.
    Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Kamidono S.
    Cancer Res; 1996 May 15; 56(10):2440-5. PubMed ID: 8625325
    [Abstract] [Full Text] [Related]

  • 2. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H, Hara I, Gohji K, Yamanaka K, Hara S, Arakawa S, Nakajima M, Kamidono S.
    Clin Cancer Res; 1999 Oct 15; 5(10):2824-9. PubMed ID: 10537348
    [Abstract] [Full Text] [Related]

  • 3. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.
    Miyake H, Yoshimura K, Hara I, Eto H, Arakawa S, Kamidono S.
    J Urol; 1997 Jun 15; 157(6):2351-5. PubMed ID: 9146669
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K, Wong L, Liu V, Park I, Zhang Q, Rejen V, Huang X, Smith ND, Jovanovic B, Lonning S, Teicher BA, Lee C.
    Urology; 2008 Jul 15; 72(1):225-9. PubMed ID: 18295867
    [Abstract] [Full Text] [Related]

  • 6. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M.
    Oncogene; 1997 Oct 23; 15(17):2069-75. PubMed ID: 9366524
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
    Ogushi T, Takahashi S, Takeuchi T, Urano T, Horie-Inoue K, Kumagai J, Kitamura T, Ouchi Y, Muramatsu M, Inoue S.
    Cancer Res; 2005 May 01; 65(9):3700-6. PubMed ID: 15867365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK, Viitanen TP, Valve EM, Seppänen JA, Loponen NT, Keskitalo JJ, Lakkakorpi PT, Härkönen PL.
    Cancer Res; 2001 May 15; 61(10):4229-37. PubMed ID: 11358849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
    Miyake H, Hara I, Yamanaka K, Muramaki M, Gleave M, Eto H.
    Oncol Rep; 2005 Feb 15; 13(2):341-5. PubMed ID: 15643522
    [Abstract] [Full Text] [Related]

  • 12. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J, Nakamoto T, Kasaoka Y, Usui T, Hamada H.
    Hiroshima J Med Sci; 2000 Mar 15; 49(1):73-82. PubMed ID: 10824460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [Abstract] [Full Text] [Related]

  • 15. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines.
    Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW, McCormick JJ.
    Oncogene; 1997 Oct 15; 15(18):2159-68. PubMed ID: 9393974
    [Abstract] [Full Text] [Related]

  • 16. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
    Ichikura H, Eto M, Ueno H, Harada M, Takayama K, Tokuda N, Tatsugami K, Naito S.
    Oncol Rep; 2006 May 15; 15(5):1333-7. PubMed ID: 16596207
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr 15; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.